Current and historical daily PE Ratio for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (
) from 2002 to May 15 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical stock (HKSE:01349) PE ratio as of May 15 2024 is 20.
More Details
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (HKSE:01349) PE Ratio (TTM) Chart
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (HKSE:01349) PE Ratio (TTM) Historical Data
View and export this data going back to 2002. Start your Free Trial
Total 1205
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Shanghai Fudan-Zhangjiang Bio-Pharmaceutical PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-15 | 20.0 | 2024-03-07 | 18.7 |
| 2024-05-14 | 20.0 | 2024-03-06 | 18.8 |
| 2024-05-13 | 20.1 | 2024-03-05 | 18.7 |
| 2024-05-10 | 20.2 | 2024-03-04 | 19.0 |
| 2024-05-09 | 20.1 | 2024-03-01 | 19.0 |
| 2024-05-08 | 19.6 | 2024-02-29 | 19.0 |
| 2024-05-07 | 19.8 | 2024-02-28 | 18.8 |
| 2024-05-06 | 19.6 | 2024-02-27 | 19.5 |
| 2024-05-03 | 19.4 | 2024-02-26 | 19.2 |
| 2024-05-02 | 19.5 | 2024-02-23 | 19.4 |
| 2024-04-30 | 19.5 | 2024-02-22 | 19.3 |
| 2024-04-29 | 19.6 | 2024-02-21 | 19.3 |
| 2024-04-26 | 19.6 | 2024-02-20 | 19.1 |
| 2024-04-25 | 19.1 | 2024-02-19 | 19.0 |
| 2024-04-24 | 19.1 | 2024-02-16 | 19.4 |
| 2024-04-23 | 19.0 | 2024-02-15 | 19.4 |
| 2024-04-22 | 19.0 | 2024-02-14 | 17.9 |
| 2024-04-19 | 18.7 | 2024-02-09 | 18.6 |
| 2024-04-18 | 18.7 | 2024-02-08 | 19.0 |
| 2024-04-17 | 18.8 | 2024-02-07 | 18.5 |
| 2024-04-16 | 18.5 | 2024-02-06 | 18.6 |
| 2024-04-15 | 18.7 | 2024-02-05 | 17.8 |
| 2024-04-12 | 19.0 | 2024-02-02 | 18.0 |
| 2024-04-11 | 19.2 | 2024-02-01 | 18.4 |
| 2024-04-10 | 19.2 | 2024-01-31 | 18.3 |
| 2024-04-09 | 19.1 | 2024-01-30 | 18.5 |
| 2024-04-08 | 18.9 | 2024-01-29 | 18.8 |
| 2024-04-05 | 18.4 | 2024-01-26 | 19.4 |
| 2024-04-03 | 19.6 | 2024-01-25 | 19.6 |
| 2024-04-02 | 19.5 | 2024-01-24 | 18.9 |
| 2024-03-28 | 19.4 | 2024-01-23 | 18.3 |
| 2024-03-27 | 17.8 | 2024-01-22 | 18.3 |
| 2024-03-26 | 17.9 | 2024-01-19 | 19.2 |
| 2024-03-25 | 18.2 | 2024-01-18 | 19.4 |
| 2024-03-22 | 18.6 | 2024-01-17 | 19.4 |
| 2024-03-21 | 19.0 | 2024-01-16 | 20.1 |
| 2024-03-20 | 18.9 | 2024-01-15 | 20.3 |
| 2024-03-19 | 18.8 | 2024-01-12 | 20.4 |
| 2024-03-18 | 19.0 | 2024-01-11 | 20.7 |
| 2024-03-15 | 19.0 | 2024-01-10 | 20.5 |
| 2024-03-14 | 19.2 | 2024-01-09 | 20.4 |
| 2024-03-13 | 19.3 | 2024-01-08 | 20.4 |
| 2024-03-12 | 19.5 | 2024-01-05 | 20.8 |
| 2024-03-11 | 19.1 | 2024-01-04 | 20.9 |
| 2024-03-08 | 18.9 | 2024-01-03 | 20.8 |
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (HKSE:01349) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
ISIN : CNE1000000W4
Share Class Description:
HKSE:01349: Class HCompare
Compare
Traded in other countries / regions
688505.China01349.Hong KongFDY.Germany IPO Date
2002-08-13Description
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd is engaged in the research, development, manufacturing, and sale of biopharmaceutical products. Its product portfolio includes ALA (Aminolevulinic acid Hydrochloride); FuMeiDa and Libord. Geographically, it derives revenue from Mainland China.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers